PL356541A1 - 2-(1H-indol-3-ylo)-2-okso-acetamidy o działaniu przeciwnowotworowym - Google Patents

2-(1H-indol-3-ylo)-2-okso-acetamidy o działaniu przeciwnowotworowym

Info

Publication number
PL356541A1
PL356541A1 PL00356541A PL35654100A PL356541A1 PL 356541 A1 PL356541 A1 PL 356541A1 PL 00356541 A PL00356541 A PL 00356541A PL 35654100 A PL35654100 A PL 35654100A PL 356541 A1 PL356541 A1 PL 356541A1
Authority
PL
Poland
Prior art keywords
acetamides
indol
oxo
antitumor activity
colon
Prior art date
Application number
PL00356541A
Other languages
English (en)
Inventor
Ernesto Menta
Nicoletta Pescalli
Original Assignee
Novuspharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma S.P.A. filed Critical Novuspharma S.P.A.
Publication of PL356541A1 publication Critical patent/PL356541A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL00356541A 1999-12-23 2000-12-21 2-(1H-indol-3-ylo)-2-okso-acetamidy o działaniu przeciwnowotworowym PL356541A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
PCT/EP2000/013068 WO2001047916A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity

Publications (1)

Publication Number Publication Date
PL356541A1 true PL356541A1 (pl) 2004-06-28

Family

ID=11384182

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356541A PL356541A1 (pl) 1999-12-23 2000-12-21 2-(1H-indol-3-ylo)-2-okso-acetamidy o działaniu przeciwnowotworowym

Country Status (24)

Country Link
US (1) US6753342B2 (pl)
EP (1) EP1244652B1 (pl)
JP (1) JP2003519140A (pl)
KR (1) KR100795533B1 (pl)
CN (1) CN1250542C (pl)
AT (1) ATE302772T1 (pl)
AU (1) AU776332B2 (pl)
BR (1) BR0016553A (pl)
CA (1) CA2395205A1 (pl)
CZ (1) CZ20022170A3 (pl)
DE (1) DE60022227T2 (pl)
EA (1) EA004925B1 (pl)
ES (1) ES2246918T3 (pl)
HU (1) HUP0203524A3 (pl)
IL (2) IL150329A0 (pl)
IT (1) IT1315267B1 (pl)
MX (1) MXPA02006217A (pl)
NO (1) NO323312B1 (pl)
NZ (1) NZ519689A (pl)
PL (1) PL356541A1 (pl)
SK (1) SK285682B6 (pl)
TR (1) TR200201613T2 (pl)
WO (1) WO2001047916A1 (pl)
ZA (1) ZA200204964B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1076657T3 (da) 1998-04-28 2004-11-08 Elbion Ag Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
IT1318641B1 (it) 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same
SG146624A1 (en) 2003-09-11 2008-10-30 Kemia Inc Cytokine inhibitors
RU2376286C2 (ru) * 2004-03-11 2009-12-20 Актелион Фармасьютиклз Лтд Производные индол-1-илуксусной кислоты
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
JP5420395B2 (ja) 2006-04-07 2014-02-19 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｐ結合カセット輸送体の調節剤
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
WO2008019357A2 (en) * 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
RU2569678C2 (ru) 2010-04-22 2015-11-27 Вертекс Фармасьютикалз Инкорпорейтед Способ получения циклоалкилкарбоксамидо-индольных соединений
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
WO2012135027A2 (en) * 2011-03-25 2012-10-04 The Research Foundation Of State University Of New York Thiolactone antibiotics
AU2013290444B2 (en) 2012-07-16 2018-04-26 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
PL3925607T5 (pl) 2014-04-15 2026-06-01 Vertex Pharmaceuticals Incorporated Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
CN115785079B (zh) * 2022-11-28 2024-02-13 沈阳药科大学 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0841924T3 (da) * 1995-08-02 2003-02-10 Univ Newcastle Ventures Ltd Benzimidazolforbindelser
CO4970714A1 (es) * 1997-09-05 2000-11-07 Boehringer Mannheim Gmbh Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DK1076657T3 (da) * 1998-04-28 2004-11-08 Elbion Ag Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling

Also Published As

Publication number Publication date
TR200201613T2 (tr) 2002-10-21
MXPA02006217A (es) 2004-02-26
IL150329A0 (en) 2002-12-01
EP1244652B1 (en) 2005-08-24
NO20022976D0 (no) 2002-06-20
IL150329A (en) 2006-07-05
WO2001047916A1 (en) 2001-07-05
CZ20022170A3 (cs) 2002-09-11
US20030158153A1 (en) 2003-08-21
CA2395205A1 (en) 2001-07-05
ES2246918T3 (es) 2006-03-01
CN1413205A (zh) 2003-04-23
ATE302772T1 (de) 2005-09-15
IT1315267B1 (it) 2003-02-03
DE60022227D1 (de) 2005-09-29
HUP0203524A3 (en) 2008-01-28
DE60022227T2 (de) 2006-06-22
SK285682B6 (sk) 2007-06-07
EA200200558A1 (ru) 2002-12-26
KR100795533B1 (ko) 2008-01-16
NO20022976L (no) 2002-06-20
EA004925B1 (ru) 2004-10-28
EP1244652A1 (en) 2002-10-02
ZA200204964B (en) 2004-01-29
BR0016553A (pt) 2002-09-17
HUP0203524A2 (hu) 2003-03-28
JP2003519140A (ja) 2003-06-17
ITMI992693A0 (it) 1999-12-23
ITMI992693A1 (it) 2001-06-23
SK8962002A3 (en) 2002-11-06
CN1250542C (zh) 2006-04-12
AU2170401A (en) 2001-07-09
NO323312B1 (no) 2007-03-12
US6753342B2 (en) 2004-06-22
AU776332B2 (en) 2004-09-02
KR20020063247A (ko) 2002-08-01
NZ519689A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
IL150329A0 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
TR199901653T2 (xx) Fitalazinonlar.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
MXPA02010088A (es) Derivados de ecteinascidina antitumorales.
PL338339A1 (en) Novel derivatives of tetrazole
MXPA05007296A (es) Compuestos de (2-carboxamido)(3-amino)tiofeno.
PL341239A1 (en) Dihydrobenzofuranes
ATE231143T1 (de) Triarylimidazole
YU1302A (sh) Derivati aminotiazola i njihova primena kao liganada crf receptora
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
DE60005689D1 (de) Neue aminobenzophenone
SE9903290D0 (sv) Novel compounds
SI1377574T1 (pl)
BG106937A (en) Novel indole derivatives
GB9907055D0 (en) Antibacterial agents
ZA983231B (en) Substituted benzyloxyimino compounds.
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
ES2159489A1 (es) Nuevos derivados de imidazol con actividad antiinflamatoria.
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
ES2166710A1 (es) Nuevos compuestos heterociclicos con actividad antiinflamatoria.
PL373989A1 (pl) Nowe benzonaftyrydyny
BG105329A (en) N-substituted azabicycloheptane derivatives, production and use thereof
MX9706968A (es) Compuesto de tiocarbamoilo.

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed